Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05465954 |
|---|---|
| Brief Title: | Efineptakin Alfa and Pembrolizumab for the Treatment of Recurrent Glioblastoma |
| First Submitted : | July 18, 2022 |
| First Submitted that Met QC Criteria : | July 18, 2022 |
| First Posted : | July 20, 2022 |
| Last Update Submitted that Met QC Criteria : | February 1, 2023 |
| Last Update Posted : | February 2, 2023 |